Building on the great achievement of the Third edition of the EURETINA Innovation Spotlight (EIS), we are keeping the momentum going and hosting EIS 2026 on Wednesday, 30 September, at VIECON – Vienna Congress & Convention Center, Vienna, preceding the EURETINA Annual Congress.
The Spotlight will include panel discussions and talks by selected Industry Leaders, Biomedical Innovators, Regulators and Investors, as well as networking opportunities.
We will be covering the many exciting areas of biomedical and engineering innovation in retina.
When is it?
EIS will take place on Wednesday 30 September 2026 at VIECON – Vienna Congress & Convention Center, Vienna. The schedule and programme information will be available soon.
Who is it for?
The goal of EIS is to foster collaboration, communication and contact directly between industry, regulators, investors, researchers and physicians involved or interested in the retinal innovation space.
For Further Information
Please contact [email protected] for registration information and [email protected] for sponsorship options.
Dear Colleagues,
We are thrilled to announce the third edition of the Euretina Innovation Spotlight (EIS) to take place at the 25th Euretina Congress in Paris on Wednesday, 3rd September 2025.
EIS offers an engaging programme of panel discussions and talks, which has been curated directly by members of the Euretina Executive and Board. The meeting attracts key opinion leaders in the field of ophthalmology, including physicians, researchers, regulators, and investors. It offers a dynamic platform for collaboration and networking in retinal innovation, and we are very excited to build on the momentum of our past two successful events.
EIS ’25 also sees the introduction of a quick-fire session dedicated to emerging biotech companies to present their strategies in cutting-edge innovations in retina. Submissions will be accepted during a limited period and presentation slots are extremely limited.
Lastly, we are excited to once again offer a variety of sponsorship opportunities, and we warmly invite our industry partners to join our those already enlisted to support EIS ‘25. We look forward to collaborating in developing EIS into one of the most significant and influential meetings in the field of retinal innovation.
Warm regards,
Anat Loewenstein
President, Euretina
On behalf of the EIS Committee
